CN105434634A - Traditional Chinese medicine composition for treating anemia - Google Patents

Traditional Chinese medicine composition for treating anemia Download PDF

Info

Publication number
CN105434634A
CN105434634A CN201610016585.5A CN201610016585A CN105434634A CN 105434634 A CN105434634 A CN 105434634A CN 201610016585 A CN201610016585 A CN 201610016585A CN 105434634 A CN105434634 A CN 105434634A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
traditional chinese
anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610016585.5A
Other languages
Chinese (zh)
Inventor
吴杰
吕萌
张磊
王静
潘琳莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610016585.5A priority Critical patent/CN105434634A/en
Publication of CN105434634A publication Critical patent/CN105434634A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn

Abstract

The invention belongs to the technical field of internal hematology, in particular relates to a traditional Chinese medicine composition for treating anemia. The traditional Chinese medicine composition for treating anemia is prepared from liquoric root, astragalus membranaceus, codonopsis pilosula, hairyvein agrimony, human placenta, semen nelumbinis, dried longan pulp, polygonum multiflorum, fructus jujubae, fructus mori, dog kidney, epimedium wushanense and largehead atractylodes rhizome. The traditional Chinese medicine composition has the beneficial effects that as the traditional Chinese medicine composition is prepared from traditional Chinese medicines, by taking invigorating qi and blood and tonifying kidney to enhance physique as principle of treatment, the cure rate is fast; anemia cannot relapse after being healed; moreover, the traditional Chinese medicine composition has no side effects, and also has a good regulation effect on physical health.

Description

A kind of Chinese medicine composition for the treatment of anemia
Technical field
The invention belongs to blood internal medicine technical field, be specifically related to a kind of Chinese medicine composition for the treatment of anemia.
Background technology
The sickness rate of anemia is high, comprises iron deficiency anemia, macrocytic, aplastic anemia and hemolytic anemia four kinds.Wherein modal is iron deficiency anemia, and with child and anemia of pregnant woman's sickness rate for height, China's less than 7 years old infantile anemia sickness rate is up to 40%.The weight of Anemia depends primarily on the degree of anemia and produces reason and the speed of anemia, and the faster symptom of speed producing anemia is more serious, and the anemia slowly occurred is due to the adaptability of human body and replacement, and symptom is relatively light.General iron deficiency anemia does not need Drug therapy, and diet raises treating blood disorders cell and hemoglobin level will return to normal level.The Anemic patients of the overwhelming majority then needs just can return to normal level by the intervention of medicine.Current western medical treatment is mainly symptomatic treatment, immunosuppressant therapy, there is erious adverse reaction, immunosuppressant therapy, causes the resistance of patient to decline, easily causes some complication; The cure rate of western medical treatment is low, and easily recurrence after curing, and adopt western medical treatment comparatively large to the damage of human body, and the course for the treatment of is longer, causes huge shade to the psychosoma of patient.The traditional Chinese medical science and Chinese medicine then also exist advantage in treatment anemia, and Chinese medicine and Chinese patent medicine can produce therapeutical effect to polytype anemia.
Summary of the invention
The present invention, in order to make up the defect of prior art, provides a kind of Chinese medicine composition for the treatment of anemia.
The Chinese medicine composition for the treatment of anemia of the present invention, its raw material composition by quality proportioning is: Radix Glycyrrhizae 2-10 part; Radix Astragali 10-25 part; Radix Codonopsis 10-26 part; Herba Agrimoniae 5-15 part; Placenta Hominis 3-5 part; Semen Nelumbinis 5-15 part; Arillus Longan 5-15 part; Radix Polygoni Multiflori 5-15 part; Fructus Jujubae 5-8 part; Fructus Mori 10-18 part; Testis et Pentis Canis 3-10 part; Epimedium wushanense 1-3 part; Rhizoma Atractylodis Macrocephalae 3-10 part.The drug effect of each medicine composition:
Radix Glycyrrhizae: [meridian distribution of property and flavor] property is put down, sweet in the mouth.GUIXIN warp, stomach warp, spleen channel, lung meridian.
[effect and effect] invigorating the spleen and replenishing QI, eliminating phlegm and stopping cough, emergency analgesic therapy, the property of medicine that is in harmonious proportion.The Qi-tonifying drug of classifying under belonging to qi-restoratives medicine.
The Radix Astragali: [meridian distribution of property and flavor] slightly warm in nature, sweet in the mouth.Return spleen channel, lung meridian.
[effect and effect] invigorating QI to consolidate the body surface resistance, diuresis, expelling pus and toxin by strengthening QI, granulation promoting.Belong to the Qi-tonifying drug of qi-restoratives medicine subordinate classification.
Radix Codonopsis: [meridian distribution of property and flavor] property is put down, sweet in the mouth.Return spleen channel, lung meridian.
[effect and effect] invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.Belong to the Qi-tonifying drug of qi-restoratives medicine subordinate classification.
Herba Agrimoniae: [meridian distribution of property and flavor] property is put down, bitter in the mouth, puckery.GUIXIN warp, Liver Channel.
[effect and effect] astringing to arrest bleeding, preventing the attack (or recurrence) of malaria, dysentery relieving, removing toxic substances.Belong to the astringent hemostatic of hemorrhage subordinate classification.
Placenta Hominis: [meridian distribution of property and flavor] is warm in nature is sweet in the mouth, salty.GUIXIN warp, lung meridian, kidney channel.
[effect and effect] the kidney warming mends essence, nourishing blood and invigorating qi.Belong to the Qi-tonifying drug of qi-restoratives medicine subordinate classification.
Semen Nelumbinis: [meridian distribution of property and flavor] property is put down, sweet in the mouth, puckery.Return spleen channel, kidney channel, heart channel.
[effect and effect] spleen reinforcing antidiarrheal, supplementing the kidney to control the nocturnal, tranquilizing by nourishing the heart.Belong to the controlling nocturnal emission with astringent drugs reducing urination leukorrhagia stopping medicine of astringent medicinal subordinate classification.
Arillus Longan: [meridian distribution of property and flavor] is warm in nature, sweet in the mouth.GUIXIN warp, spleen channel.
[effect and effect] invigorating the heart and spleen, nourishing blood to tranquillize the mind.Belong to the Qi-tonifying drug of qi-restoratives medicine subordinate classification.
Radix Polygoni Multiflori: [meridian distribution of property and flavor] is warm in nature is bitter in the mouth, sweet, puckery.Return Liver Channel, kidney channel, heart channel.
[effect and effect] detoxifies, eliminating carbuncle, loosening bowel to relieve constipation.The hematonic of classifying under belonging to qi-restoratives medicine.Radix Polygoni Multiflori tool defying age, strengthen immunity, promote adrenocortical function.Hemocyte new life and growth, adjusting blood lipid and atherosclerosis can be promoted, and tool hepatoprotective effect.
Fructus Jujubae: [meridian distribution of property and flavor] is warm in nature, sweet in the mouth.Return spleen channel, stomach warp, heart channel.
[effect and effect] invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind.Belong to the Qi-tonifying drug of qi-restoratives medicine subordinate classification.
Fructus Mori: [meridian distribution of property and flavor] is cold in nature, sweet in the mouth, acid.GUIXIN warp, Liver Channel, kidney channel.
[effect and effect] YIN nourishing of enriching blood, promote the production of body fluid and moisturize.Belong to the hematonic of qi-restoratives medicine subordinate classification.
Testis et Pentis Canis: [meridian distribution of property and flavor] salty in the mouth, warm in nature.Return kidney channel.
[effect and effect] warming the kidney to invigorate YANG, strengthening and nourishing marrow and essence.Belong to the yang-tonifying drug of qi-restoratives medicine subordinate classification.
Epimedium wushanense: [meridian distribution of property and flavor] is warm in nature, acrid in the mouth, sweet.Return Liver Channel, kidney channel.
[effect and effect] kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.Belong to the yang-tonifying drug of qi-restoratives medicine subordinate classification.
The Rhizoma Atractylodis Macrocephalae: [meridian distribution of property and flavor] is warm in nature, sweet in the mouth, hardship.Return spleen channel, stomach warp.
[effect and effect] spleen invigorating, QI invigorating, dampness diuretic, hidroschesis, antiabortive.Belong to the Qi-tonifying drug of qi-restoratives medicine subordinate classification.
Said medicine being made method of the present invention is:
By above-mentioned each medicine Radix Glycyrrhizae, the Radix Astragali, Radix Codonopsis, Herba Agrimoniae, Placenta Hominis, Semen Nelumbinis, Arillus Longan, Radix Polygoni Multiflori, Fructus Jujubae, Fructus Mori, Testis et Pentis Canis, Epimedium wushanense and the Rhizoma Atractylodis Macrocephalae by the synthesis of its weight, with being decocted in water for oral dose, potion, divided early, evening took for 2 times, within 10th, is a course for the treatment of every day.
The invention has the beneficial effects as follows: a kind of Chinese medicine composition for the treatment of anemia of the present invention adopts Chinese medicine to be made, with the Therapeutic Principle of benefiting vital QI and blood, kidney-tonifying health-care, cure speed soon, no longer recur more, and without any side effects, also have good opsonic action to healthy.
Detailed description of the invention
Below provide specific embodiments of the invention, be used for being further described formation of the present invention.
Embodiment 1
The Chinese medicine composition for the treatment of anemia of the present invention, its raw material composition by quality proportioning is: 2 parts, Radix Glycyrrhizae; The Radix Astragali 10 parts; Radix Codonopsis 10 parts; Herba Agrimoniae 5 parts; Placenta Hominis 3 parts; 5 parts, Semen Nelumbinis; Arillus Longan 5 parts; Radix Polygoni Multiflori 5 parts; 5 parts, Fructus Jujubae; 10 parts, Fructus Mori; Testis et Pentis Canis 3 parts; Epimedium wushanense 1 part; The Rhizoma Atractylodis Macrocephalae 3 parts.
Embodiment 2
The Chinese medicine composition for the treatment of anemia of the present invention, its raw material composition by quality proportioning is: 8 parts, Radix Glycyrrhizae; The Radix Astragali 18 parts; Radix Codonopsis 15 parts; Herba Agrimoniae 9 parts; Placenta Hominis 4 parts; 12 parts, Semen Nelumbinis; Arillus Longan 11 parts; Radix Polygoni Multiflori 9 parts; 6 parts, Fructus Jujubae; 13 parts, Fructus Mori; Testis et Pentis Canis 8 parts; Epimedium wushanense 2 parts; The Rhizoma Atractylodis Macrocephalae 7 parts.
Embodiment 3
The Chinese medicine composition for the treatment of anemia of the present invention, its raw material composition by quality proportioning is: 10 parts, Radix Glycyrrhizae; The Radix Astragali 25 parts; Radix Codonopsis 26 parts; Herba Agrimoniae 15 parts; Placenta Hominis 5 parts; 15 parts, Semen Nelumbinis; Arillus Longan 15 parts; Radix Polygoni Multiflori 15 parts; 8 parts, Fructus Jujubae; 18 parts, Fructus Mori; Testis et Pentis Canis 10 parts; Epimedium wushanense 3 parts; The Rhizoma Atractylodis Macrocephalae 10 parts.
Case is illustrated:
Lee, man, birth in 1964, when 42 years old, check out anemia, breathe hard, the symptom such as cardiopalmus, lean body mass, uneasy sleeping at night, fatigue and weak, I went out to carry out Chinese traditional treatment afterwards, after taking 1 course for the treatment of of this prescription, symptom is alleviated to some extent, and after 3 courses for the treatment of, symptom disappears entirely, recovery from illness.
Huang, female, 52 years old, grade teacher, when in June, 2007 examines, pale complexion, dizziness, tinnitus, breathe hard, weak etc., readme: suffer from iron deficiency anemia existing 3 years, many places are treated, weak effect.Use Drug therapy of the present invention, treat the 6th day, symptom just starts to alleviate, and treat the 15th day, symptom is clearly better, and treat the 27th day, symptom all disappears, and with arriving examination in hospital, all are normal, have no recurrence up till now.
Curative effect determinate standard
Cure: clinical symptoms and sign disappear or significantly improve situation, and routine blood test, peripheral blood film, reticulocyte count or bone marrow aspiration, marrow cell coating plate classification etc. inspections are recovered or are clearly better.
Improve: clinical symptoms and sign comparatively before take a turn for the better, the Index for examinations such as routine blood test, peripheral blood film, reticulocyte count or bone marrow aspiration, bone marrow are thin, the classification of born of the same parents' smear are improved.
Invalid: without taking a turn for the better before clinical symptoms and sign, routine blood test, peripheral blood film, reticulocyte count or bone marrow aspiration, marrow cell coating plate classification comparatively.
Therapeutic outcome: through routine with Drug therapy Anemic patients 44 of the present invention, wherein man 13 example, female 31 example, healing 39 is routine, and take a turn for the better 5 examples; Cure rate reaches 88%, and total effective rate reaches 100%.
The present invention is not limited to above-mentioned embodiment, anyone should learn make under enlightenment of the present invention with the present invention, there is identical or close technical scheme, all fall within protection scope of the present invention.

Claims (3)

1. treat a Chinese medicine composition for anemia, it is characterized in that, its raw material composition and ratio is: Radix Glycyrrhizae 2-10 part; Radix Astragali 10-25 part; Radix Codonopsis 10-26 part; Herba Agrimoniae 5-15 part; Placenta Hominis 3-5 part; Semen Nelumbinis 5-15 part; Arillus Longan 5-15 part; Radix Polygoni Multiflori 5-15 part; Fructus Jujubae 5-8 part; Fructus Mori 10-18 part; Testis et Pentis Canis 3-10 part; Epimedium wushanense 1-3 part; Rhizoma Atractylodis Macrocephalae 3-10 part.
2. a kind of Chinese medicine composition for the treatment of anemia according to claim 1, is characterized in that: its raw material composition and ratio described is: 10 parts, Radix Glycyrrhizae; The Radix Astragali 25 parts; Radix Codonopsis 26 parts; Herba Agrimoniae 15 parts; Placenta Hominis 5 parts; 15 parts, Semen Nelumbinis; Arillus Longan 15 parts; Radix Polygoni Multiflori 15 parts; 8 parts, Fructus Jujubae; 18 parts, Fructus Mori; Testis et Pentis Canis 10 parts; Epimedium wushanense 3 parts; The Rhizoma Atractylodis Macrocephalae 10 parts.
3. a kind of Chinese medicine composition for the treatment of anemia according to claim 1, is characterized in that: its raw material composition and ratio described is: 8 parts, Radix Glycyrrhizae; The Radix Astragali 18 parts; Radix Codonopsis 15 parts; Herba Agrimoniae 9 parts; Placenta Hominis 4 parts; 12 parts, Semen Nelumbinis; Arillus Longan 11 parts; Radix Polygoni Multiflori 9 parts; 6 parts, Fructus Jujubae; 13 parts, Fructus Mori; Testis et Pentis Canis 8 parts; Epimedium wushanense 2 parts; The Rhizoma Atractylodis Macrocephalae 7 parts.
CN201610016585.5A 2016-01-12 2016-01-12 Traditional Chinese medicine composition for treating anemia Pending CN105434634A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610016585.5A CN105434634A (en) 2016-01-12 2016-01-12 Traditional Chinese medicine composition for treating anemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610016585.5A CN105434634A (en) 2016-01-12 2016-01-12 Traditional Chinese medicine composition for treating anemia

Publications (1)

Publication Number Publication Date
CN105434634A true CN105434634A (en) 2016-03-30

Family

ID=55545565

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610016585.5A Pending CN105434634A (en) 2016-01-12 2016-01-12 Traditional Chinese medicine composition for treating anemia

Country Status (1)

Country Link
CN (1) CN105434634A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106860683A (en) * 2017-04-19 2017-06-20 李淑雯 One kind treats anginal Chinese medicine composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1111996A (en) * 1994-05-18 1995-11-22 邱友德 Chinese patent medicine for treatment of aplastic anemia and leucopenia
CN1137918A (en) * 1996-05-15 1996-12-18 赵翠兰 Traditional Chinese medicine-"Zengxuening" for regulating organism balance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1111996A (en) * 1994-05-18 1995-11-22 邱友德 Chinese patent medicine for treatment of aplastic anemia and leucopenia
CN1137918A (en) * 1996-05-15 1996-12-18 赵翠兰 Traditional Chinese medicine-"Zengxuening" for regulating organism balance

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
肖国士: "《中医秘方全书（珍藏本）超值版》", 30 June 2012 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106860683A (en) * 2017-04-19 2017-06-20 李淑雯 One kind treats anginal Chinese medicine composition

Similar Documents

Publication Publication Date Title
CN102552773B (en) Drug for treating bronchitis and bronchial asthma of 7-15 year old children
CN102526674A (en) Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven
CN103721236A (en) Traditional Chinese medicinal composition for treating gastropathy
CN101164588A (en) Traditional Chinese medicine for treating yin deficiency and fire excess type palpitation
CN102614442B (en) Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis
CN104383390A (en) Chinese traditional medicine preparation for treating lung cancer
CN103127326A (en) Pharmaceutical composition for treating osteoarthritis and preparation method thereof
CN102698093B (en) Chinese medicinal composition for treating liver and kidney deficiency type hypertension and preparation method thereof
CN1049827C (en) Anti-cancer powder
CN101194998B (en) Chinese medicine for treating diabetes
CN102805830A (en) Traditional Chinese medicine composite for treating acne
CN105434634A (en) Traditional Chinese medicine composition for treating anemia
CN103784813A (en) Chinese herbal medicine formula for treating postpartum hypogalactia and preparation method thereof
CN102935163A (en) Traditional Chinese preparation for treating hyperosteogeny
CN101703660B (en) Anti-aging medicament
CN106237056A (en) A kind of Chinese medicine decoction treating chronic bronchitis
CN101953902A (en) Pharmaceutical composition for postoperative recovery of chemoradiation
CN102727765B (en) Internally-used medicine for treating aplastic anemia by nourishing yin and yang
CN104042839A (en) Traditional Chinese medicine composition for treating tinea versicolor
CN103330896B (en) Preparation method of powder for treating postpartum nonspecific vaginitis
CN103432422B (en) Traditional Chinese medicine for treating chronic gastritis
CN106177572A (en) A kind of Chinese medicine decoction treating aplastic anemia
CN105535817A (en) A traditional Chinese medicine composition containing argy wormwood leaves and used for treating cervical spondylosis and a preparing method thereof
CN105770815A (en) Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof
CN104998120A (en) Traditional Chinese medicine composition for promoting postpartum recovery of pregnant women and promoting lactation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160330